scispace - formally typeset
R

Radboud J E M Dolhain

Researcher at Erasmus University Rotterdam

Publications -  109
Citations -  5236

Radboud J E M Dolhain is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Pregnancy & Rheumatoid arthritis. The author has an hindex of 29, co-authored 96 publications receiving 4356 citations. Previous affiliations of Radboud J E M Dolhain include Erasmus University Medical Center & Boston Children's Hospital.

Papers
More filters
Journal ArticleDOI

Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study.

TL;DR: It is demonstrated that patients with rheumatoid arthritis achieve remission during pregnancy and deteriorate postpartum, although less frequently than previously described.
Journal ArticleDOI

Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production.

TL;DR: Th17 cells, but not Th1 cells, cooperated with RASFs in a proinflammatory feedback loop, revealing a potential mechanism by which human Th17 cells drive chronic destructive disease in patients with RA.
Journal ArticleDOI

Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: Results of a national prospective study

TL;DR: Pregnancy outcome in women with well-controlled RA is comparable with that in the general population, and the effect of prednisone on birth weight is mediated by a lower gestational age at delivery, whereas a higher level of disease activity independently influences birth weight negatively, suggesting an immune-mediated mechanism.
Journal ArticleDOI

Glycosylation profiling of immunoglobulin G (IgG) subclasses from human serum

TL;DR: A robust method for the isolation of IgG subclasses using protein A (binds IgG1, IgG2, and IgG4) and protein G ( binds additionally IgG3) at the 96‐well plate level, which is suitable for automation is described and revealed distinct differences in N‐glycosylation between the four IgGSubclasses.